NATTOPHARMA AS

0283 OSLO

Finances

Return on Equity

167,49 %

Current Ratio

1,12

Debt-to-Equity Ratio

0,03

Key figures (NOK)	2022	2021	2020	2019
Revenue	182 629 000	217 558 000	217 968 000	131 150 000
Net Income	154 744 000	−37 982 000	68 592 000	−13 696 000
Total Assets	274 657 000	228 995 000	255 687 000	160 478 000
Total Equity	92 392 000	144 496 000	181 914 000	101 342 000

Income (NOK)	2022	2021	2020	2019
Revenue	182 629 000	217 558 000	217 968 000	131 150 000
Expenditure	177 861 000	228 204 000	196 420 000	131 629 000
Operating Profit	4 768 000	−10 646 000	21 548 000	−479 000
Financial Income	455 000	65 000	1 849 000	3 245 000
Financial Costs	−148 463 000	970 000	−20 657 000	16 897 000
Financial Balance	148 918 000	−905 000	22 506 000	−13 652 000
Earnings Before Tax	153 686 000	−11 551 000	44 054 000	−14 131 000
Tax	−1 058 000	26 431 000	−24 538 000	−435 000
Net Income	154 744 000	−37 982 000	68 592 000	−13 696 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	73 083 000	100 667 000	130 184 000	83 904 000
Total Current Assets	201 574 000	128 328 000	125 503 000	76 574 000
Total Assets	274 657 000	228 995 000	255 687 000	160 478 000
Total Retained Equity	0	−59 825 000	−20 266 000	−76 804 000
Total Equity	92 392 000	144 496 000	181 914 000	101 342 000
Total Long-Term Debt	2 932 000	9 668 000	7 391 000	15 742 000
Total Current Debt	179 331 000	74 831 000	66 382 000	43 394 000
Total Equity and Debt	274 655 000	228 995 000	255 687 000	160 478 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	182 629 000	216 112 000	214 468 000	127 119 000
Other Income	0	1 446 000	3 500 000	4 031 000
Revenue	182 629 000	217 558 000	217 968 000	131 150 000
Cost of Goods Sold	95 466 000	117 592 000	123 127 000	76 232 000
Salary Costs	28 518 000	43 945 000	39 274 000	30 942 000
Depreciation	12 578 000	17 937 000	11 374 000	7 948 000
Impairment	19 069 000	0	0	0
Expenditure	177 861 000	228 204 000	196 420 000	131 629 000
Operating Profit	4 768 000	−10 646 000	21 548 000	−479 000
Financial Income	455 000	65 000	1 849 000	3 245 000
Financial Costs	−148 463 000	970 000	−20 657 000	16 897 000
Financial Balance	148 918 000	−905 000	22 506 000	−13 652 000
Dividends	154 744 000	0	0	0
Net Income	154 744 000	−37 982 000	68 592 000	−13 696 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	7 538 000	7 901 000	7 444 000
Total Intangible Assets	67 559 000	87 903 000	94 266 000	49 880 000
Real Eastate	2 114 000	9 347 000	6 455 000	0
Machinery and Plant Facilities	3 410 000	0	0	0
Fixtures	0	3 417 000	643 000	2 117 000
Total Tangible Assets	5 524 000	12 764 000	7 098 000	2 117 000
Total Fiancial Fixed Assets	0	0	28 820 000	31 907 000
Total Fixed Assets	73 083 000	100 667 000	130 184 000	83 904 000
Stock	22 523 000	70 253 000	49 353 000	33 667 000
Total Investments	0	0	0	0
Cash, Bank	6 036 000	24 851 000	42 485 000	14 619 000
Total Current Assets	201 574 000	128 328 000	125 503 000	76 574 000
Total Assets	274 657 000	228 995 000	255 687 000	160 478 000
Total Equity	92 392 000	144 496 000	181 914 000	101 342 000
Short-Term Group Debt	0	23 012 000	0	6 000 000
Total Long-Term Debt	2 932 000	9 668 000	7 391 000	15 742 000
Creditors	18 551 000	30 247 000	40 786 000	29 185 000
Unpaid Taxes	0	2 790 000	0	0
Dividends	154 744 000	0	0	0
Other Current Debt	10 149 000	18 782 000	18 008 000	8 209 000
Total Current Debt	179 331 000	74 831 000	66 382 000	43 394 000
Total Equity and Debt	274 655 000	228 995 000	255 687 000	160 478 000

Financial indicators	2022	2021	2020	2019
Return on Equity	167,49 %	−26,29 %	37,71 %	−13,51 %
Debt-to-Equity Ratio	0,03	0,07	0,04	0,16
Operating Profit Margin	2,61 %	−4,89 %	9,89 %	−0,37 %
Current Ratio	1,12	1,71	1,89	1,76
Quick Ratio	1,29	28,03	7,37	7,87
Equity Ratio	0,34	0,63	0,71	0,63
Gross Profit Margin	47,73 %	45,95 %	43,51 %	41,87 %